Back to LBRX
MORGAN STANLEY LBRX Position History
LB Pharmaceuticals Inc • Healthcare
Quarters held
29
Latest value
$212K
Q3 2026
Peak value
$2.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $152K |
| Q3 2025 | $152K |
| Q4 2025 | $65K |
| Q4 2025 | $913 |
| Q4 2025 | $61K |
| Q4 2025 | $418K |
| Q4 2025 | $3K |
| Q4 2025 | $65K |
| Q4 2025 | $913 |
| Q4 2025 | $61K |
| Q4 2025 | $418K |
| Q4 2025 | $3K |
| Q1 2026 | $349K |
| Q1 2026 | $671K |
| Q1 2026 | $122K |
| Q1 2026 | $888 |
| Q1 2026 | $23K |
| Q2 2026 | $524K |
| Q2 2026 | $178K |
| Q2 2026 | $626K |
| Q2 2026 | $198K |
| Q2 2026 | $746 |
| Q2 2026 | $135K |
| Q3 2026 | $721K |
| Q3 2026 | $239K |
| Q3 2026 | $2.4M |
| Q3 2026 | $940K |
| Q3 2026 | $1K |
| Q3 2026 | $212K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $212K | 5.5K | — | — |
| Q3 2026 | $1K | 31 | — | — |
| Q3 2026 | $940K | 24.5K | — | — |
| Q3 2026 | $2.4M | 61.4K | — | — |
| Q3 2026 | $239K | 6.2K | — | — |
| Q3 2026 | $721K | 18.8K | — | — |
| Q2 2026 | $135K | 4.2K | — | — |
| Q2 2026 | $746 | 23 | — | — |
| Q2 2026 | $198K | 6.1K | — | — |
| Q2 2026 | $626K | 19.3K | — | — |
| Q2 2026 | $178K | 5.5K | — | — |
| Q2 2026 | $524K | 16.1K | — | — |
| Q1 2026 | $23K | 941 | — | — |
| Q1 2026 | $888 | 36 | — | — |
| Q1 2026 | $122K | 4.9K | — | — |
| Q1 2026 | $671K | 27.2K | — | — |
| Q1 2026 | $349K | 14.1K | — | — |
| Q4 2025 | $3K | 154 | — | — |
| Q4 2025 | $418K | 18.8K | — | — |
| Q4 2025 | $61K | 2.8K | — | — |
| Q4 2025 | $913 | 41 | — | — |
| Q4 2025 | $65K | 2.9K | — | — |
| Q4 2025 | $3K | 154 | — | — |
| Q4 2025 | $418K | 18.8K | — | — |
| Q4 2025 | $61K | 2.8K | — | — |
| Q4 2025 | $913 | 41 | — | — |
| Q4 2025 | $65K | 2.9K | — | — |
| Q3 2025 | $152K | 9.6K | — | — |
| Q3 2025 | $152K | 9.6K | — | — |
Other funds holding LBRX
$128.7M
$108.8M
$82.7M
$74.6M
$53.9M